IRC21 BASIC INFORMATION
| Standard Name | IRC21 1 |
|---|---|
| Systematic Name | YMR073C |
| Feature Type | ORF, Verified |
| Description | Putative protein of unknown function; proposed to be involved in resistance to carboplatin and cisplatin; shares similarity to a human cytochrome oxidoreductase; null mutant displays increased levels of spontaneous Rad52p foci (1, 2)
|
| Name Description | Increased Recombination Centers 1 |
| GO Annotations | All IRC21 GO evidence and references |
|---|---|
| View Computational GO annotations for IRC21 | |
| Molecular Function | |
| Manually curated |
|
| Biological Process | |
| High-throughput | |
| Cellular Component | |
| High-throughput |
| Mutant Phenotype | All IRC21 Phenotype details and references |
|---|---|
| Large-scale survey | |
| null |
|
| overexpression |
| Interactions | IRC21 All interactions details and references |
|---|---|
| 8 total interaction(s) for 8 unique genes/features. | |
| Physical Interactions |
|
| Genetic Interactions |
|
| External Links | All Associated Seq | Entrez Gene | Entrez RefSeq Protein | MIPS | UniProtKB |
|---|
| Primary SGDID | S000004677 |
|---|
ADDITIONAL INFORMATION for IRC21
REFERENCES CITED ON THIS PAGE [View Complete Literature Guide for IRC21]
| 1) | Alvaro D, et al. (2007) Genome-wide analysis of Rad52 foci reveals diverse mechanisms impacting recombination. PLoS Genet 3(12):e228 |
| 2) | Lee W, et al. (2005) Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet 1(2):e24 |






